// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

A virtual SIC: A new way of diagnosing occupational asthma in the COVID-19 pandemic

Vicky Moore - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Sputum transcriptomic analysis of air pollutant signatures: link to asthma severity and phenotype

Angelica Tiotiu - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Ambient air pollution and respiratory health in sub-Saharan African children: a cross-sectional analysis

Yutong Cai - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Long-term air pollution exposure, greenness and health-related quality of life (HRQOL) in ECRHS

Valerie Siroux - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Characterisation of a paediatric population referred for a dysfunctional breathing assessment

Laura Blazey - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Dyspnea

N/A

Adverse drug reactions of leukotriene receptor antagonists in children with asthma: a systematic review

Eleanor Dixon - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

A systematic review of the proportion of adolescents recruited to RCTs of asthma treatments for adults and adolescents

Amy Nuttall - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Mould in the homes of asthmatic children is associated with socioeconomic deprivation, reduced lung function and unscheduled healthcare visits

Karl Holden - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Deprescribing montelukast in children with asthma: a systematic review

Eleanor Dixon - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Montelukast

Evaluation of the teach-to-goal method in improving inhaler technique in paediatric asthma patients

Orla Mallon - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Assessment of current practice of paediatric respiratory and allergy teams in Cambridge University Hospital during the COVID-19 pandemic era and optimisation of the service

Elizabeth Powell - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

The change in exhaled nitric oxide in adolescents – a longitudinal cohort study

Ran Wang - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Nitric oxide

Caregiver burden in paediatric asthma and preschool wheeze and the role of asthma education

Ember Lu - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Severity scores published for acute wheeze in preschool children: a systematic review

Emma Wilkinson - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Management of children aged 1-5 admitted and treated for a clinical diagnosis of acute asthma compared to those aged 6-16 in secondary care in England and Wales

Alexander Adamson - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

N/A

Using quality improvement project to improve childhood asthma outcomes in low resource setting

Justus Simba - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Childhood asthma care in a secondary hospital in Kenya: Parental perceptions from a quality improvement project

Justus Simba - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Effect of zinc supplementation in children with asthma

Sajith Jayasree Sadanandan - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Asthma symptom severity and diagnosis in adolescents in sub-Saharan Africa

Victoria Oyenuga - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Nitric oxide

Dupilumab efficacy in children with uncontrolled, moderate-to-severe asthma with and without an allergic phenotype

Nikolaos Papadopoulos - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Dupilumab

Copyright © 2026. QuantiNova All rights reserved